logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
S

Sakari Hietanen

University of Turku and Turku University Hospital
H指数:26
被引数:2,686

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Exploring survival-associated transcriptomic subtypes in ovarian cancer using RNAseq from FFPE tissues in a clinical trial cohort

探索卵巢癌中与生存相关的转录组亚型：使用来自临床 trial 研究队列的石蜡包埋组织 RNAseq 数据

Translational Oncology
IF4.1
2026-03-190
OAAI
Maj K Kjeldsen; Frederik Otzen Bagger; Henrik Roed; Gitte-Bettina Nyvang; Charlotte Aaquist Haslund; Anja Oer Knudsen; Anne Krejbjerg Motavaf; Susanne Malander; Maarit Anttila; Gabriel Lindahl; Johanna Mäenpää; Maria Dimoula; Theresa Werner; Trine Zeeberg Iversen; Sakari Hietanen; Lars Fokdal; Hanna Dahlstrand; Line Bjørge; Michael Birrer; Mansoor Raza Mirza
Multi-omics analysis reveals the attenuation of the interferon pathway as a driver of chemo-refractory ovarian cancer

多组学分析揭示了干扰素通路衰减是化疗抵抗性卵巢癌的驱动因素。

Cell Reports Medicine
IF10.6
2025-08-290
OAAI
Daria Afenteva; Rong Yu; Anna Rajavuori; Marina Salvadores; Inga-Maria Launonen; Kari Lavikka; Kaiyang Zhang; Anna Pirttikoski; Giovanni Marchi; Sanaz Jamalzadeh; Veli-Matti Isoviita; Yilin Li; Giulia Micoli; Erdogan Pekcan Erkan; Matias M. Falco; Daniela Ungureanu; Alexandra Lahtinen; Jaana Oikkonen; Sakari Hietanen; Anna Vähärautio; Inderpreet Sur; Anni Virtanen; Anniina Färkkilä; Johanna Hynninen; Taru A. Muranen; Jussi Taipale; Sampsa Hautaniemi
ENGOT-en11/GOG-3053/KEYNOTE-B21: A phase III study of pembrolizumab or placebo in combination with adjuvant chemotherapy with or without radiotherapy in patients with newly diagnosed, high-risk endometrial cancer

ENGOT-en11/GOG-3053/KEYNOTE-B21: 一项关于帕博利珠单抗或安慰剂联合辅助化疗，且根据情况联合或不联合放疗，在 newly diagnosed、high-risk endometrial cancer 患者中进行的 III 期研究

ANNALS OF ONCOLOGY
IF65.4
2024-09-010
PRE
Van Gorp, T.; Rob, L.; Lu, W.; Backes, F.; Ortac, F.; Hasegawa, K.; Hietanen, S. H.; Savarese, A.; Laenen, A.; Kim, Y. M.; Bodnar, L.; Barretina Ginesta, M. P.; Gilbert, L.; Pothuri, B.; Chen, X.; Lichfield, J.; Wang, W.; Orlowski, R. J.; Lortholary, A.; Slomovitz, B. M.
Patient-reported outcomes (PROs) in patients (pts) with mismatch repair deficient (dMMR)/microsatellite instability-high (MSI-H) primary advanced or recurrent endometrial cancer (pA/rEC) in the ENGOT-EN6-NSGO/GOG3031/RUBY trial
ANNALS OF ONCOLOGY
IF65.4
2023-10-012
PRE
Valabrega, G.; Powell, M. A.; Hietanen, S.; Miller, E. M.; Novak, Z.; Holloway, R.; Denschlag, D.; Myers, T.; Thijs, A. M.; Pennington, K.; Gilbert, L.; Fleming, E.; Copeland, L.; Gogoi, R.; Podzielinski, I.; Cloven, N.; Meyers, O.; Garside, J.; Mirza, M. R.; Black, D.
Efficacy and safety of maintenance olaparib and bevacizumab in ovarian cancer patients aged ≥65 years from the PAOLA-1/ENGOT-ov25 trial

来自PAOLA-1/ENGOT-ov25试验的 ≥ 65岁卵巢癌患者维持奥拉帕尼和贝伐单抗的疗效和安全性

EUROPEAN JOURNAL OF CANCER
IF7.1
2023-03-0112
OAAI
Sabatier, Renaud; Rousseau, Frederique; Joly, Florence; Cropet, Claire; Montegut, Coline; Frindte, Johanna; Cinieri, Saverio; Alia, Eva M. Guerra; Polterauer, Stephan; Yoshida, Hiroyuki; Vergote, Ignace; Colombo, Nicoletta; Hietanen, Sakari; Largillier, Remi; Canzler, Ulrich; Gratet, Alain; Marme, Frederik; Favier, Laure; Pujade-Lauraine, Eric; Ray-Coquard, Isabelle
Functional Homologous Recombination Assay on FFPE Specimens of Advanced High-Grade Serous Ovarian Cancer Predicts Clinical Outcomes
CLINICAL CANCER RESEARCH
IF10.2
2023-02-2010
OAAI
Pikkusaari, Sanna; Tumiati, Manuela; Virtanen, Anni; Oikkonen, Jaana; Li, Yilin; Perez-Villatoro, Fernando; Muranen, Taru; Salko, Matilda; Huhtinen, Kaisa; Kanerva, Anna; Koskela, Heidi; Tapper, Johanna; Koivisto-Korander, Riitta; Joutsiniemi, Titta; Haltia, Ulla-Maija; Lassus, Heini; Hautaniemi, Sampsa; Farkkila, Anniina; Hynninen, Johanna; Hietanen, Sakari; Carpen, Olli; Kauppi, Liisa

研究方向

暂未获取到该数据
J
Johanna Hynninen
H 指数:27论文数:270被引数:2,995
S
Sampsa Hautaniemi
H 指数:58论文数:510被引数:1.1万
J
Jaana Oikkonen
H 指数:19论文数:230被引数:1,306
K
Kaisa Huhtinen
H 指数:30论文数:244被引数:2,926
A
Anni Virtanen
H 指数:19论文数:191被引数:1,659
K
Kari Lavikka
H 指数:8论文数:125被引数:404
O
Olli Carpén
H 指数:69论文数:459被引数:1.8万
A
Antti Häkkinen
H 指数:18论文数:86被引数:1,085
A
Alexandra Lahtinen
H 指数:11论文数:56被引数:490
S
Sanaz Jamalzadeh
H 指数:6论文数:18被引数:530